HK1091229A1 - Production of poxviruses with adherent or non adherent avian cell lines - Google Patents
Production of poxviruses with adherent or non adherent avian cell linesInfo
- Publication number
- HK1091229A1 HK1091229A1 HK06111514.8A HK06111514A HK1091229A1 HK 1091229 A1 HK1091229 A1 HK 1091229A1 HK 06111514 A HK06111514 A HK 06111514A HK 1091229 A1 HK1091229 A1 HK 1091229A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- adherent
- poxviruses
- production
- cell lines
- avian cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24151—Methods of production or purification of viral material
- C12N2710/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03291813A EP1500699A1 (en) | 2003-07-22 | 2003-07-22 | Production of vaccinia virus with adherent or non adherent avian cell lines |
FR0314389 | 2003-12-09 | ||
PCT/IB2004/002621 WO2005007840A1 (en) | 2003-07-22 | 2004-07-22 | Production of poxviruses with adherent or non adherent avian cell lines |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1091229A1 true HK1091229A1 (en) | 2007-01-12 |
Family
ID=34081825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK06111514.8A HK1091229A1 (en) | 2003-07-22 | 2006-10-19 | Production of poxviruses with adherent or non adherent avian cell lines |
Country Status (15)
Country | Link |
---|---|
US (3) | US7432101B2 (sl) |
EP (2) | EP1646715B1 (sl) |
JP (2) | JP4787156B2 (sl) |
KR (1) | KR101121971B1 (sl) |
AT (1) | ATE467678T1 (sl) |
AU (1) | AU2004257939B2 (sl) |
CA (1) | CA2531565C (sl) |
DE (1) | DE602004027141D1 (sl) |
DK (1) | DK1646715T3 (sl) |
ES (1) | ES2345820T3 (sl) |
HK (1) | HK1091229A1 (sl) |
PL (1) | PL1646715T3 (sl) |
PT (1) | PT1646715E (sl) |
SI (1) | SI1646715T1 (sl) |
WO (1) | WO2005007840A1 (sl) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7445924B2 (en) * | 2000-11-23 | 2008-11-04 | Bavarian Nordic A/S | Modified Vaccinia Ankara virus variant and cultivation method |
FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
CN1692156B (zh) | 2002-09-05 | 2011-05-11 | 巴法里安诺迪克有限公司 | 在无血清条件下培养原代细胞和扩增病毒的方法 |
DE602004027141D1 (de) * | 2003-07-22 | 2010-06-24 | Vivalis | Produktion von poxviren mit adhärenten oder nicht adhärenten vogelzellinien |
EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
AU2011253998B2 (en) * | 2005-04-11 | 2014-04-24 | Valneva | Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines |
FR2884255B1 (fr) * | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
FR2898909A1 (fr) | 2006-03-24 | 2007-09-28 | Agronomique Inst Nat Rech | Combinaison de marqueurs de cellules aviaires |
WO2007135133A1 (en) * | 2006-05-19 | 2007-11-29 | Vivalis | Avian cell lines derived from primordial germ cells useful for the production of substances of interest |
DK2029756T3 (en) | 2006-06-20 | 2017-02-13 | Transgene Sa | PROCEDURE FOR PREPARING POXVIRA AND POXVIRUS COMPOSITIONS |
EP2054507A1 (en) * | 2006-08-09 | 2009-05-06 | Vivalis | Method of production of transgenic avian using embryonic stem cells |
CA2680130C (en) * | 2007-03-05 | 2016-01-12 | Caridianbct, Inc. | Cell expansion system and methods of use |
EP1985305A1 (en) * | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
TWI614342B (zh) | 2007-07-03 | 2018-02-11 | 存斯精菱公司 | 禽類永生化細胞系 |
US8357531B2 (en) | 2007-07-03 | 2013-01-22 | Transgene S.A. | Immortalized avian cell lines |
PL214884B1 (pl) * | 2008-09-29 | 2013-09-30 | Inst Immunologii I Terapii Doswiadczalnej Pan | Test ELISA do wykrywania w surowicy bydlecej przeciwcial przeciwko antygenowi powierzchniowemu gp51 BLV |
ES2539045T3 (es) | 2009-01-19 | 2015-06-25 | Innate Pharma | Anticuerpos anti-KIR3D |
EP2393922A1 (en) * | 2009-02-06 | 2011-12-14 | GlaxoSmithKline Biologicals S.A. | Purification of virus or viral antigens by density gradient ultracentrifugation |
EP2429580A1 (en) | 2009-05-12 | 2012-03-21 | Transgene SA | Method for orthopoxvirus production and purification |
AU2011281982B2 (en) | 2010-07-20 | 2015-12-17 | Bavarian Nordic A/S | Method for harvesting expression products |
EP2614141B1 (en) * | 2010-09-07 | 2019-07-31 | Technion Research & Development Foundation Limited | Novel methods and culture media for culturing pluripotent stem cells |
WO2012048275A2 (en) | 2010-10-08 | 2012-04-12 | Caridianbct, Inc. | Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system |
EP2660316A1 (en) | 2012-05-02 | 2013-11-06 | Helmholtz-Zentrum für Infektionsforschung GmbH | Avian cell line and its use in production of protein |
US20140255447A1 (en) * | 2013-03-05 | 2014-09-11 | Biomune Company | Production of avian embryo cells |
CN105793411B (zh) | 2013-11-16 | 2018-04-17 | 泰尔茂比司特公司 | 生物反应器中的细胞扩增 |
EP3613841B1 (en) | 2014-03-25 | 2022-04-20 | Terumo BCT, Inc. | Passive replacement of media |
US10077421B2 (en) | 2014-04-24 | 2018-09-18 | Terumo Bct, Inc. | Measuring flow rate |
US20160090569A1 (en) | 2014-09-26 | 2016-03-31 | Terumo Bct, Inc. | Scheduled Feed |
AU2015357225B2 (en) | 2014-12-01 | 2020-04-09 | Transgene Sa | Stable liquid vaccinia virus formulations |
WO2016088243A1 (ja) * | 2014-12-05 | 2016-06-09 | 株式会社ニコン | 判定装置、観察システム、観察方法、そのプログラム、細胞の製造方法、および細胞 |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US20190134190A1 (en) | 2016-05-04 | 2019-05-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
EP3464565A4 (en) | 2016-05-25 | 2020-01-01 | Terumo BCT, Inc. | CELL EXPANSION |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
JP7393945B2 (ja) | 2017-03-31 | 2023-12-07 | テルモ ビーシーティー、インコーポレーテッド | 細胞増殖 |
US11624046B2 (en) | 2017-03-31 | 2023-04-11 | Terumo Bct, Inc. | Cell expansion |
WO2018210804A1 (en) | 2017-05-15 | 2018-11-22 | Janssen Vaccines & Prevention B.V. | Stable virus-containing composition |
JP7406377B2 (ja) | 2017-05-15 | 2023-12-27 | ヤンセン ファッシンズ アンド プリベンション ベーフェー | 安定なウイルス含有組成物 |
IL271558B2 (en) | 2017-06-21 | 2024-01-01 | Transgene | A vaccine tailored to the individual |
BR112020024354A2 (pt) | 2018-05-30 | 2021-03-02 | Institute For Research In Biomedicine | manipulação de linfócitos b utilizando ctidina desaminase induzida por ativação endógena |
US20210187100A1 (en) | 2018-09-06 | 2021-06-24 | Bavarian Nordic A/S | Storage Improved Poxvirus Compositions |
CN113474449A (zh) | 2018-11-23 | 2021-10-01 | 瓦尔尼瓦公司 | 包括禽类干细胞的食物产品 |
MX2021006115A (es) * | 2019-01-17 | 2021-07-07 | Boehringer Ingelheim Animal Health Usa Inc | Medio libre de suero para produccion de vacuna aviar y usos del mismo. |
BR112022017438A2 (pt) | 2020-03-12 | 2022-10-18 | Bavarian Nordic As | Composições que melhoram a estabilidade do poxvírus |
CN115943206A (zh) * | 2020-06-22 | 2023-04-07 | 可隆生命科学株式会社 | 利用悬浮细胞大量生产痘苗病毒的方法 |
US20230256057A1 (en) | 2020-07-13 | 2023-08-17 | Transgene | Treatment of immune depression |
WO2023213763A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5340740A (en) | 1992-05-15 | 1994-08-23 | North Carolina State University | Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process |
FR2726003B1 (fr) | 1994-10-21 | 2002-10-18 | Agronomique Inst Nat Rech | Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires |
US5989805A (en) * | 1995-10-27 | 1999-11-23 | Board Of Trustees Operating Michigan State University | Immortal avian cell line to grow avian and animal viruses to produce vaccines |
US5672485A (en) | 1996-08-13 | 1997-09-30 | Regents Of The University Of Minnesota | Immortalized cell lines for virus growth |
ES2224210T3 (es) | 1996-11-12 | 2005-03-01 | Pfizer Inc. | Vacuna de neospora viva atenuada. |
ATE312405T1 (de) * | 2002-02-19 | 2005-12-15 | Cellergy Ltd | Elektrochemischer kondensator und dessen herstellung |
FR2836924B1 (fr) * | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
JP2006509526A (ja) * | 2002-12-13 | 2006-03-23 | アヴェンティス パストゥール インコーポレイテッド | トリ胚性幹細胞上におけるalvacの産生 |
DE602004027141D1 (de) * | 2003-07-22 | 2010-06-24 | Vivalis | Produktion von poxviren mit adhärenten oder nicht adhärenten vogelzellinien |
EP1528101A1 (en) * | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
-
2004
- 2004-07-22 DE DE602004027141T patent/DE602004027141D1/de active Active
- 2004-07-22 US US10/565,281 patent/US7432101B2/en not_active Expired - Fee Related
- 2004-07-22 ES ES04744255T patent/ES2345820T3/es active Active
- 2004-07-22 SI SI200431453T patent/SI1646715T1/sl unknown
- 2004-07-22 AT AT04744255T patent/ATE467678T1/de active
- 2004-07-22 KR KR1020067001289A patent/KR101121971B1/ko not_active IP Right Cessation
- 2004-07-22 PL PL04744255T patent/PL1646715T3/pl unknown
- 2004-07-22 CA CA2531565A patent/CA2531565C/en not_active Expired - Fee Related
- 2004-07-22 WO PCT/IB2004/002621 patent/WO2005007840A1/en active Application Filing
- 2004-07-22 EP EP04744255A patent/EP1646715B1/en not_active Not-in-force
- 2004-07-22 JP JP2006520937A patent/JP4787156B2/ja not_active Expired - Fee Related
- 2004-07-22 AU AU2004257939A patent/AU2004257939B2/en not_active Ceased
- 2004-07-22 PT PT04744255T patent/PT1646715E/pt unknown
- 2004-07-22 EP EP09174819A patent/EP2143788A1/en not_active Withdrawn
- 2004-07-22 DK DK04744255.3T patent/DK1646715T3/da active
-
2006
- 2006-10-19 HK HK06111514.8A patent/HK1091229A1/xx not_active IP Right Cessation
-
2008
- 2008-10-01 US US12/243,437 patent/US7771980B2/en not_active Expired - Fee Related
-
2009
- 2009-11-03 US US12/611,806 patent/US20100111999A1/en not_active Abandoned
-
2011
- 2011-05-27 JP JP2011118610A patent/JP5416169B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1646715A1 (en) | 2006-04-19 |
KR101121971B1 (ko) | 2012-03-09 |
WO2005007840A1 (en) | 2005-01-27 |
JP2011224009A (ja) | 2011-11-10 |
US20090239286A1 (en) | 2009-09-24 |
EP1646715B1 (en) | 2010-05-12 |
KR20060057577A (ko) | 2006-05-26 |
ES2345820T3 (es) | 2010-10-04 |
CA2531565A1 (en) | 2005-01-27 |
JP5416169B2 (ja) | 2014-02-12 |
PT1646715E (pt) | 2010-08-09 |
CA2531565C (en) | 2014-02-11 |
PL1646715T3 (pl) | 2010-10-29 |
US7771980B2 (en) | 2010-08-10 |
US20060233834A1 (en) | 2006-10-19 |
SI1646715T1 (sl) | 2010-09-30 |
JP4787156B2 (ja) | 2011-10-05 |
US7432101B2 (en) | 2008-10-07 |
DE602004027141D1 (de) | 2010-06-24 |
AU2004257939B2 (en) | 2008-06-05 |
ATE467678T1 (de) | 2010-05-15 |
US20100111999A1 (en) | 2010-05-06 |
AU2004257939A1 (en) | 2005-01-27 |
DK1646715T3 (da) | 2010-08-16 |
JP2006527995A (ja) | 2006-12-14 |
EP2143788A1 (en) | 2010-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1091229A1 (en) | Production of poxviruses with adherent or non adherent avian cell lines | |
WO2009077134A3 (en) | Use of rna for reprogramming somatic cells | |
WO2010147395A3 (en) | Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same | |
WO2008036447A3 (en) | Pluripotent stem cell culture | |
JP2008212150A5 (sl) | ||
WO2010006312A3 (en) | Methods and compositions for producing carbon-based products in microorganisms | |
HK1080507A1 (en) | Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions | |
GB2432846B (en) | Medium and culture of embryonic stem cells | |
JP2006527995A5 (sl) | ||
DK1483369T3 (da) | Fuglecellelinier til fremstiling af stoffer af interesse | |
WO2004055155A3 (en) | Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same | |
MXPA05009096A (es) | Metodo de cultivo celular libre de animal. | |
GB2449772A (en) | Large scale production of stem cells | |
WO2003023018A3 (en) | A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use | |
WO2007070315A3 (en) | Improved production of glycoproteins using manganese | |
AR069956A1 (es) | Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas | |
WO2007115337A3 (en) | Chondrocyte differentiation from human embryonic stem cells and their use in tissue engineering | |
WO2007016366A3 (en) | Defined culture conditions of human embryonic stem cells | |
WO2003038076A1 (fr) | Cellules mesenchymateuses immortalisees et leur utilisation | |
WO2011160128A3 (en) | Cardiomyocyte medium with dialyzed serum | |
WO2017213469A3 (ko) | 남조류 스피룰리나 추출물을 함유하는 세포 배양액, 이의 제조방법, 및 이를 이용한 세포의 배양방법 | |
NZ595833A (en) | Method of producing a lipolytic enzyme | |
GB2450599A (en) | Automated culture of stem cells | |
BRPI0914805B8 (pt) | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição | |
WO2012046065A3 (en) | Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a* |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160722 |